Latest

nAChR

Featured Neuroscience Open Neuroscience Articles

·October 29, 2018·4 min read

Making Mice Lose Weight by Imitating Effects From Cold and Nicotine

By stimulating cold and nicotine receptors, researchers successfully improved metabolism in mice, helping them to lose weight. Further studies will investigate whether the same results can be achieved in humans.

Image shows the interpeduncular nucleus of a mouse brain.

Featured Neuroscience

·December 28, 2017·5 min read

Brain Research Points the Way to New Treatments for Nicotine Addiction

Researchers have identified specific chemical changes in the brain that drive nicotine addiction. The findings could lead to new treatments to help break the addiction.

Featured Neurology Neuroscience Open Neuroscience Articles Pain

·May 8, 2017·6 min read

How One Drug Could Affect Pain, Memory and Nicotine Addiction

Researchers are developing a drug that enhances the function of nicotinic acetylcholine receptors. The drug could have three different applications in relieving pain, slowing memory loss in aging people and as a smoking cessation medication.

Featured Neurology Pain

·February 21, 2017·3 min read

Compound From Marine Snails May Provide Alternative to Opioids

Researchers have discovered a compound from marine snails that is able to block pain by targeting a pathway not associated with opioids.

Image shows a person surrounded by smoke.

Featured Genetics Psychology

·January 23, 2017·4 min read

Nicotine Normalizes Brain Activity Deficits That Are Key to Schizophrenia

Study sheds light on how nicotine affects the brains of those with schizophrenia, and why those with the disease tend to be heavy smokers.

Image shows the chemical structure of nAChR.

Featured Neurology Neuroscience

·June 18, 2016·2 min read

Nicotinic Acetylcholine Receptors in the Pathology of Alzheimer’s Disease

A new study looks at the role nicotinic acetylcholine receptors play in Alzheimer's disease.

Diagram shows a ligand-gated ion channel.

Featured Neuroscience Open Neuroscience Articles

·May 11, 2016·3 min read

Targeted Orphaned Domain May Lead to Drug Therapies

A new study reveals tthe serotonin type 3A ICD assembles into stable pentamers in solution in the absence of the other two domains, thought to be the drivers for oligomerization.